Xiangyu Medical Co. Ltd. A - Asset Resilience Ratio
Xiangyu Medical Co. Ltd. A (688626) has an Asset Resilience Ratio of 1.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688626 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how Xiangyu Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See Xiangyu Medical Co. Ltd. A balance sheet quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Xiangyu Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688626 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥50.18 Million | 1.53% |
| Total Liquid Assets | CN¥50.18 Million | 1.53% |
Asset Resilience Insights
- Limited Liquidity: Xiangyu Medical Co. Ltd. A maintains only 1.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Xiangyu Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Xiangyu Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for Xiangyu Medical Co. Ltd. A (2021–2023)
The table below shows the annual Asset Resilience Ratio data for Xiangyu Medical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 6.26% | CN¥162.19 Million ≈ $23.73 Million |
CN¥2.59 Billion ≈ $379.31 Million |
-20.62pp |
| 2022-12-31 | 26.88% | CN¥636.47 Million ≈ $93.14 Million |
CN¥2.37 Billion ≈ $346.52 Million |
-2.82pp |
| 2021-12-31 | 29.70% | CN¥648.14 Million ≈ $94.84 Million |
CN¥2.18 Billion ≈ $319.38 Million |
-- |
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more